News

Growth Capital Allows Alimera to Fulfill Its Milestone Obligation Triggered by FDA Approval of ILUVIEN® ATLANTA, Sept. 30, 2014 /PRNewswire/ — Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that it has received a $25 million advance from Hercules Technology Growth Capital, Inc. (NYSE: HTGC) (Hercules). The payment →

LOS ANGELES, Aug. 5, 2014 (GLOBE NEWSWIRE) — Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, and SWK Funding LLC (“SWK”), a wholly-owned subsidiary of SWK Holdings Corporation, as the agent, entered into a credit agreement (the “Credit Agreement”) pursuant to which the lenders party thereto provide Response Genetics (the “Company”) a term →

REDWOOD CITY, Calif. – July 28, 2014 – PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, today announced that it has closed up to $50 million in secured debt financing from an investment fund managed by Pharmakon Advisors and $12 million in an extension on its Series B preferred stock. This financing was →

Strength of SMS CRM business model and global reach validated by large investors July 7, 2014 Sunnyvale, CA – July 7, 2014 – mBlox, the largest global provider of application-to-person (A2P) text messaging, today announced the completion of a new capital raise of $43.5 million to fund the continued growth of its global business. “We see →

BRANFORD, Conn. (June 30, 2014) – CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announced that on Friday, June 27, 2014, the Company entered into a Loan and Security Agreement (the “Loan Agreement”) with General Electric Capital Corporation (“GECC”). Pursuant to the Loan Agreement, GECC is providing the →

MENLO PARK, Calif.–(BUSINESS WIRE)–Ceterix™ Orthopaedics, Inc., a developer of novel surgical tools for arthroscopic procedures, today announced that the company has closed $18 million in new financing. Previous investors Novo A/S, Versant Ventures and 5AM Ventures participated in the round, which also included debt financing from Silicon Valley Bank and Oxford Finance. Armentum Partners acted →

EWING, N.J., May 12, 2014 (GLOBE NEWSWIRE) — Celator Pharmaceuticals, Inc., (CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that it has entered into a loan agreement with Hercules Technology Growth Capital, Inc. (HTGC), a specialty finance company that provides customized debt financing to companies in life sciences and →

ATLANTA, April 25, 2014 /PRNewswire/ — Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that its United Kingdom subsidiary,Alimera Sciences Limited (Limited), has entered into a Loan and Security Agreement with Hercules Technology Growth Capital, Inc. (NYSE: HTGC) (Hercules) for a term loan in the principal amount of up →

SEATTLE, WA | April 3, 2014 – NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has entered into a term loan agreement with Capital Royalty L.P. and certain of its affiliates. The agreement provides NanoString with up to $45 million of available borrowing capacity. →

SAN FRANCISCO, CA–(Marketwired – March 11, 2014) – Armentum Partners, an emerging leader in debt capital raising services and royalty transactions, announced today that industry veteran Hutch Corbett has joined the firm as a Managing Partner. Hutch was most recently a Managing Director at TriplePoint Capital, and has extensive experience both as an operator and a →